EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (AMEX: NBY, www.novabaypharma.com), announces the retirement of Jack O’Reilly, its Senior Vice-President of Corporate and Business Development, effective December 31, 2008. Mr. O’Reilly has also resigned as a member of the Board of Directors. Mr. O’Reilly’s decision to retire was the result of hearing loss that has been increasingly preventing him from playing a full role within the company.
